Voltammetric behaviour of mitoxantrone at a DNA-biosensor

Biosensors and Bioelectronics

Volumn 13, Issue 7-8, 1998, Pages 861-867

  Brett, A M Oliveira ^a   MacEdo, T R A ^b   Raimundo, D ^b   Marques, M H ^b   Serrano, S H P ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioelectrochemistry; DNA interaction; DNA biosensor; Mitoxantrone; Voltammetry

Indexed keywords

MITOXANTRONE; VOLTAMMETRY;

AROMATIC COMPOUNDS; BIOCHEMISTRY; CARBON; DNA; ELECTROCHEMICAL ELECTRODES; ELECTROCHEMISTRY; NITROGEN COMPOUNDS; REACTION KINETICS;

BIOSENSORS;

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DNA; DOUBLE STRANDED DNA; MITOXANTRONE; SINGLE STRANDED DNA;

BIOSENSOR; CONFERENCE PAPER; DNA DAMAGE; DRUG DNA INTERACTION; DRUG MECHANISM; ELECTROCHEMISTRY; ELECTRODE; ELECTRON TRANSPORT; POTENTIOMETRY; SENSOR;

ANIMALS; BIOSENSING TECHNIQUES; DNA; HUMANS; MITOXANTRONE;

EID: 0032191659     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0956-5663(98)00053-0     Document Type: Article

References (26)

1. Bowden G.T., Roberts R., Alberts D.S., Peng Y.M., Garcia D. Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene. Cancer Research. 45:1985;4915-4920.
2. Brett C.M.A., Oliveira Brett A.M., Serrano S.H.P. On the adsorption and electrochemical oxidation of DNA at glassy carbon electrodes. Journal of Electroanalytical Chemistry. 366:1994;225-231.
3. Capranico G., Zunino F. DNA topoisomerase-trapping antitumour drugs. United European Journal of Cancer. 22:1992;1024-1030.
4. Dunn C.J., Goa K.L. Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. Drugs and Aging. 9(2):1996;122-147.
5. Fox M.E., Smith P.J. Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the DNA intercalators mAMSA and mitoxantrone. Cancer Research. 50:1990;5813-5818.
6. Foye W.O., Vajragupta O.P.A., Sengupta S.K. DNA-binding specificity and RNA polymerase inhibitory activity of bis(aminoalkyl) anthraquinones and bis(methylthio) vinylquinolinium iodides. Journal of Pharmaceutical Science. 71(2):1982;253-257.
7. Hoogsteen K. The structure of crystals containing a hydrogen-bonded complex of 1-methylthymine and 9-methyladenine. Acta Crystallographia. 12:1959;822-823.
8. Kapuscinski J., Darzynkiewicz Z. Interactions of antitumor agents ametantrone and mitoxantrone (Novantrone) with double-stranded DNA. Biochemistry and Pharmacology. 34(24):1985;4203-4213.
9. Kapuscinski J., Darzynkiewicz Z. Relationship between the pharmacological activity of antitumor drugs ametantrone and mitoxantrone (Novantrone) and their ability to condense nucleic acids. Proceedings of the National Academy of Science USA. Biochemistry. 83:1986;6302-6306.
10. Kapuscinski J., Darzynkiewicz Z., Traganos F., Melamed M.R. Interactions of a new antitumor agents, 1,4-dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10- anthracenedione, with nucleic acids. Biochemistry and Pharmacology. 30:1981;231-240.
11. Johnston, B.H., 1992. Hydroxylamine and methoxylamine as probes of DNA structure. In: Lilley, D.M.J., Dahlberg, J.E. (Eds.), Methods in Enzymology, Part B, ch. 10. Academic Press, San Diego, pp. 180-194.
12. Lown J.W., Hanstock C.C., Brabley R.D., Scraba D.G. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy. Molecular Pharmacology. 25:1984;178-184.
13. Lown J.W., Morgan A.R., Yen S.-F., Wang Y.-H., Wilson W.D. Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids. Biochemistry. 24:1985;4028-4035.
14. Murdock K.C., Child R.G., Fabio P.F., Angier R.B., Wallace R.E., Durr F.E., Citarella R.V. Antitumor agents. 1. 1,4-bis[(aminoalkyl)amino]-9,10-anthracenediones. Journal of Medical Chemistry. 22:1979;1024-1030.
15. Oliveira Brett A.M., Serrano S.H.P., Macedo T.A., Raimundo D., Marques M.H., La-Scalea M.A. Electrochemical determination of carboplatin in serum using a DNA-modified glassy carbon electrode. Electroanalysis. 8:1996;992-995.
16. Oliveira Brett, A.M., Serrano, S.H.P., 1997. Development of DNA-based biosensors for carcinogens. In: Nikolelis, D., Frangopol (Eds.), Current Topics in Biophysics, Biosensors, vol. 6, ch. 10. Iasi University Press, Romania.
17. Oliveira Brett A.M., Matysik F.-M. Voltammetric and sonovoltammetric studies on the oxidation of thymine and cytosine at a glassy carbon electrode. Journal of Electroanalytical Chemistry. 429:1997;95-99.
18. Oliveira Brett A.M., Serrano S.H.P., Gutz I., La-Scalea M.A., Cruz M.L. Volammetric behavior of nitroimidazoles at a DNA-biosensor. Electroanalysis. 9:1997;1132-1137.
19. Oliveira Brett, A.M., Serrano, S.H.P., Piedade, J.A.P., 1998. In: Compton, R.G. (Ed.), Electrochemistry of DNA. Comprehensive Chemical Kinetics, Applications of Kinetic Modelling (in press).
20. Potaman V.N., Sinden R.R. Stabilization of triple-helical nucleic acids by basic oligopeptides. Biochemistry. 34:1995;14885-14892.
21. Riggs, C.E., 1992. In: Perry, M.C. (Ed.), The Chemotheraphy Source Book. Williams and Wilkins, Maryland, USA, pp. 318-358.
22. Shin C., Koo H.-S. Helical periodicity of GA-alternating triple-stranded DNA. Biochemistry. 35:1996;968-972.
23. Smith I.E. Mitoxantrone (Novantrone): a review of experimental and early clinical studies. Cancer Treatment Reviews. 10:1983;103-115.
24. Soyfer, V.N., Potaman, V.N., 1995. Triple-helical Nucleic Acids. Springer, New York.
25. Wang J.C. DNA topoisomerases: why so many? Journal of Biological Chemistry. 266:1991;6659-6662.
26. Zee-Cheng R.K.-Y., Cheng C.C. Antineoplastic agents. Structure-activity relationship study of Bis/substituted aminoalkylamino/anthraquinones. Journal of Medical Chemistry. 21:1978;291-294.